Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma

NCT06963632 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06963632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06963632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2025
Completion date
December 31, 2027
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral t-cell lymphoma (ptcl)